Showing results (151-160 of 334) with videos related to
Sort By:
Pageof 34
Scandinavian Journal of Haematology|November 1, 1986
T-cell chronic lymphocytic leukaemias and T-cell lymphoma-leukaemia: heterogeneity and anomalous cell markersA S Spiers, D A Lawrence, M Levine, et al.Neurology|April 1, 1985
Motor function in the normal aging population: treatment with levodopaR P Newman, P A LeWitt, M Jaffe, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Familial Parkinson's disease: possible role of environmental factorsS Calne, B Schoenberg, W Martin, et al.Parkinsonism & Related Disorders|July 2, 2008
The role of the Lewy body in idiopathic ParkinsonismR de la Fuente-Fernandez, M Schulzer, E Mak, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1997
"Familial Parkinson's disease"--a case-control study of familiesR J Uitti, H Shinotoh, M Hayward, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective studyM J Hjermstad, S A Evensen, S O Kvaløy, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials OfficeP M Fayers, P Hopwood, A Harvey, et al.Archives of Neurology|December 1, 1978
Effect of an opiate antagonist on movement disordersJ G Nutt, A J Rosin, T Eisler, et al.Neurology|October 1, 1981
Prolactin secretion in Parkinson diseaseT Eisler, M O Thorner, R M MacLeod, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1980
CFS hydroxylase cofactor levels in some neurological diseasesA C Williams, R A Levine, T N Chase, et al.Pageof 34